Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1989 Jun;27(6):757–761. doi: 10.1111/j.1365-2125.1989.tb03437.x

The potassium channel opening drug cromakalim produces arterioselective vasodilation in the upper limbs of healthy volunteers.

D J Webb 1, N Benjamin 1, P Vallance 1
PMCID: PMC1379802  PMID: 2757892

Abstract

1. The effect of the K+ channel opening drug cromakalim on forearm blood flow during direct infusion into the brachial artery, and on the size of noradrenaline preconstricted hand veins during infusion directly into the vein, was studied in eight healthy volunteers. 2. Cromakalim (0.01-10.0 micrograms min-1) produced a dose-dependent increase in blood flow in the infused forearm, from 5.4 +/- 2.5 to 15.1 +/- 7.3 ml 100 ml-1 forearm min-1 at 10 micrograms min-1 (P less than 0.001). The half-time of offset of its action was 30 min. There was no change in blood flow in the non-infused forearm. 3. There was no increase in the size of noradrenaline pre-constricted dorsal veins during local infusion of cromakalim (0.001-1.0 microgram min-1). Glyceryl trinitrate (0.4 microgram min-1) however, completely reversed the constriction to noradrenaline (P less than 0.001). 4. The clear arterioselectivity of cromakalim, as with other members of this new class of drug, accords with the dependency of venoconstriction on receptor-operated, rather than potential-operated mechanisms which are of importance in resistance vessels. With this haemodynamic profile cromakalim may prove of value in the treatment of arterial hypertension.

Full text

PDF
757

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bolton T. B. Mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rev. 1979 Jul;59(3):606–718. doi: 10.1152/physrev.1979.59.3.606. [DOI] [PubMed] [Google Scholar]
  2. Clapham J. C., Wilson C. Anti-spasmogenic and spasmolytic effects of BRL 34915: a comparison with nifedipine and nicorandil. J Auton Pharmacol. 1987 Sep;7(3):233–242. doi: 10.1111/j.1474-8673.1987.tb00152.x. [DOI] [PubMed] [Google Scholar]
  3. Coldwell M. C., Howlett D. R. Specificity of action of the novel antihypertensive agent, BRL 34915, as a potassium channel activator. Comparison with nicorandil. Biochem Pharmacol. 1987 Nov 1;36(21):3663–3669. doi: 10.1016/0006-2952(87)90017-7. [DOI] [PubMed] [Google Scholar]
  4. Collier J. G., Robinson B. F. Comparison of effects of locally infused angiotensin I and II on hand veins and forearm arteries in man: evidence for converting enzyme activity in limb vessels. Clin Sci Mol Med. 1974 Aug;47(2):189–192. doi: 10.1042/cs0470189. [DOI] [PubMed] [Google Scholar]
  5. Cook N. S. The pharmacology of potassium channels and their therapeutic potential. Trends Pharmacol Sci. 1988 Jan;9(1):21–28. doi: 10.1016/0165-6147(88)90238-6. [DOI] [PubMed] [Google Scholar]
  6. Cook N. S., Weir S. W., Danzeisen M. C. Anti-vasoconstrictor effects of the K+ channel opener cromakalim on the rabbit aorta--comparison with the calcium antagonist isradipine. Br J Pharmacol. 1988 Nov;95(3):741–752. doi: 10.1111/j.1476-5381.1988.tb11700.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hall D., Froer K. L., Rudolph W. Serial electrocardiographic changes during long-term treatment of severe hypertension with minoxidil. J Cardiovasc Pharmacol. 1980;2 (Suppl 2):S200–S205. doi: 10.1097/00005344-198000022-00014. [DOI] [PubMed] [Google Scholar]
  8. Hamilton T. C., Weir S. W., Weston A. H. Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein. Br J Pharmacol. 1986 May;88(1):103–111. doi: 10.1111/j.1476-5381.1986.tb09476.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hamilton T. C., Weston A. H. Cromakalim, nicorandil and pinacidil: novel drugs which open potassium channels in smooth muscle. Gen Pharmacol. 1989;20(1):1–9. doi: 10.1016/0306-3623(89)90052-9. [DOI] [PubMed] [Google Scholar]
  10. Meisheri K. D., Cipkus L. A., Taylor C. J. Mechanism of action of minoxidil sulfate-induced vasodilation: a role for increased K+ permeability. J Pharmacol Exp Ther. 1988 Jun;245(3):751–760. [PubMed] [Google Scholar]
  11. Robinson B. F. Assessment of the effect of drugs on the venous system in man. Br J Clin Pharmacol. 1978 Nov;6(5):381–386. doi: 10.1111/j.1365-2125.1978.tb04600.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Robinson B. F., Collier J. G. Vascular smooth muscle. Correlations between basic properties and responses of human blood-vessels. Br Med Bull. 1979 Sep;35(3):305–312. doi: 10.1093/oxfordjournals.bmb.a071593. [DOI] [PubMed] [Google Scholar]
  13. Robinson B. F. Differences in blood vessels between species: relation to differences in blood vessels of varying type within the same species. Gen Pharmacol. 1983;14(1):43–46. doi: 10.1016/0306-3623(83)90061-7. [DOI] [PubMed] [Google Scholar]
  14. Robinson B. F., Dobbs R. J., Kelsey C. R. Effects of nifedipine on resistance vessels, arteries and veins in man. Br J Clin Pharmacol. 1980 Nov;10(5):433–438. doi: 10.1111/j.1365-2125.1980.tb01784.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. WHITNEY R. J. The measurement of volume changes in human limbs. J Physiol. 1953 Jul;121(1):1–27. doi: 10.1113/jphysiol.1953.sp004926. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Weir S. W., Weston A. H. Effect of apamin on responses to BRL 34915, nicorandil and other relaxants in the guinea-pig taenia caeci. Br J Pharmacol. 1986 May;88(1):113–120. doi: 10.1111/j.1476-5381.1986.tb09477.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES